Does the fortified milk with high iron dose improve the neurodevelopment of healthy infants? Randomized controlled trial.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
05 09 2019
Historique:
received: 06 05 2018
accepted: 20 08 2019
entrez: 7 9 2019
pubmed: 7 9 2019
medline: 15 12 2020
Statut: epublish

Résumé

Since iron plays an important role in several physiological processes, its deficiency but also overload may harm the development of children. The aim was to assess the effect of iron-fortified milk on the iron biochemical status and the neurodevelopment of children at 12 months of age. Randomized controlled trial conducted in 133 Spanish children, allocated in two groups to receive formula milk fortified with 1.2 or 0.4 mg/100 mL of iron between 6 and 12 months of age. Psychomotor (PDI) and Mental (MDI) Development Index were assessed by the Bayley Scales before and after the intervention. Maternal obstetrical and psychosocial variables were recorded. The biochemical iron status of children was measured and data about breastfeeding, anthropometry and infections during the first year of life were registered. Children fortified with 1.2 mg/100 mL of iron, compared with 0.4 mg/100 mL, showed higher serum ferritin (21.5 vs 19.1 μg/L) and lower percentage of both iron deficiency (1.1 to 5.9% vs 3.8 to 16.7%, respectively, from 6 to 12 months) and iron deficiency anemia (4.3 to 1.1% vs 0 to 4.2%, respectively, from 6 to 12 months) at the end of the intervention. No significant differences were found on neurodevelopment from 6 to 12 months between children who received high dose of Fe compared with those who received low dose. Despite differences on the iron status were observed, there were no effects on neurodevelopment of well-nourished children in a developed country after iron supplementation with doses within dietary recommendations. Follow-up studies are needed to test for long-term neurodevelopmental improvement. Retrospectively registered in ClinicalTrials.gov with the ID: NCT02690675.

Sections du résumé

BACKGROUND
Since iron plays an important role in several physiological processes, its deficiency but also overload may harm the development of children. The aim was to assess the effect of iron-fortified milk on the iron biochemical status and the neurodevelopment of children at 12 months of age.
METHODS
Randomized controlled trial conducted in 133 Spanish children, allocated in two groups to receive formula milk fortified with 1.2 or 0.4 mg/100 mL of iron between 6 and 12 months of age. Psychomotor (PDI) and Mental (MDI) Development Index were assessed by the Bayley Scales before and after the intervention. Maternal obstetrical and psychosocial variables were recorded. The biochemical iron status of children was measured and data about breastfeeding, anthropometry and infections during the first year of life were registered.
RESULTS
Children fortified with 1.2 mg/100 mL of iron, compared with 0.4 mg/100 mL, showed higher serum ferritin (21.5 vs 19.1 μg/L) and lower percentage of both iron deficiency (1.1 to 5.9% vs 3.8 to 16.7%, respectively, from 6 to 12 months) and iron deficiency anemia (4.3 to 1.1% vs 0 to 4.2%, respectively, from 6 to 12 months) at the end of the intervention. No significant differences were found on neurodevelopment from 6 to 12 months between children who received high dose of Fe compared with those who received low dose.
CONCLUSION
Despite differences on the iron status were observed, there were no effects on neurodevelopment of well-nourished children in a developed country after iron supplementation with doses within dietary recommendations. Follow-up studies are needed to test for long-term neurodevelopmental improvement.
TRIAL REGISTRATION
Retrospectively registered in ClinicalTrials.gov with the ID: NCT02690675.

Identifiants

pubmed: 31488098
doi: 10.1186/s12887-019-1679-0
pii: 10.1186/s12887-019-1679-0
pmc: PMC6727503
doi:

Substances chimiques

Iron, Dietary 0
Ferritins 9007-73-2
Iron E1UOL152H7

Banques de données

ClinicalTrials.gov
['NCT02690675']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

315

Références

Arch Dis Child. 1999 Sep;81(3):247-52
pubmed: 10451399
Pediatr Int. 2000 Dec;42(6):625-30
pubmed: 11192518
Pediatr Clin North Am. 2001 Apr;48(2):401-13
pubmed: 11339160
Annu Rev Nutr. 2001;21:1-21
pubmed: 11375427
Cochrane Database Syst Rev. 2001;(2):CD001444
pubmed: 11405989
Public Health Nutr. 2001 Apr;4(2B):537-45
pubmed: 11683548
Am J Otolaryngol. 2001 Nov-Dec;22(6):391-4
pubmed: 11713723
An Esp Pediatr. 2002 Sep;57(3):209-14
pubmed: 12199942
BMJ. 2002 Nov 16;325(7373):1142
pubmed: 12433763
Pediatrics. 2003 Oct;112(4):846-54
pubmed: 14523176
J Pediatr. 2003 Nov;143(5):582-6
pubmed: 14615726
Am J Clin Nutr. 2004 Sep;80(3):729-36
pubmed: 15321815
J Nutr. 2004 Sep;134(9):2349-54
pubmed: 15333727
Public Health Nutr. 2005 Apr;8(2):117-32
pubmed: 15877905
Nutr Rev. 2006 May;64(5 Pt 2):S34-43; discussion S72-91
pubmed: 16770951
Public Health Nutr. 2009 Apr;12(4):444-54
pubmed: 18498676
Acta Paediatr. 2008 Aug;97(8):1055-60
pubmed: 18565152
Am J Clin Nutr. 2009 Jul;90(1):76-87
pubmed: 19458014
Pediatrics. 2010 Nov;126(5):1040-50
pubmed: 20923825
Early Hum Dev. 2011 Mar;87(3):165-9
pubmed: 21256683
Arch Pediatr Adolesc Med. 2012 Mar;166(3):208-15
pubmed: 22064877
Int J Vitam Nutr Res. 1990;60(2):150-5
pubmed: 2210964
Ann Nutr Metab. 2011;59(1):59-63
pubmed: 22123641
Br J Nutr. 2013 Jan 14;109(1):103-10
pubmed: 22443990
BMC Public Health. 2012 Jul 06;12:506
pubmed: 22770558
JPEN J Parenter Enteral Nutr. 2013 Sep;37(5):599-606
pubmed: 22968710
Cochrane Database Syst Rev. 2013 Jun 06;(6):CD001444
pubmed: 23744449
CMAJ. 2013 Nov 19;185(17):E791-802
pubmed: 24130243
J Pediatr Gastroenterol Nutr. 2014 Jan;58(1):119-29
pubmed: 24135983
Lancet Glob Health. 2013 Aug;1(2):e77-e86
pubmed: 25104162
Pediatrics. 2015 Apr;135(4):723-33
pubmed: 25825534
Hong Kong J Paediatr. 2016;20(2):71-79
pubmed: 26500419
Pediatrics. 2016 Apr;137(4):
pubmed: 26936859
Am J Clin Nutr. 1989 Sep;50(3 Suppl):667-73; discussion 673-4
pubmed: 2773844
Pediatrics. 2017 Aug;140(2):null
pubmed: 28771408
Pediatr Res. 2018 Apr;83(4):760-766
pubmed: 29244799
Blood. 1974 Apr;43(4):581-90
pubmed: 4522154
J Pediatr. 1978 Mar;92(3):412-6
pubmed: 632980
Indian J Pediatr. 1981 Jan-Feb;48(390):93-8
pubmed: 7024124
J Pediatr. 1994 Oct;125(4):527-34
pubmed: 7523647
Acta Paediatr. 1995 Sep;84(9):1035-44
pubmed: 8652956
MMWR Recomm Rep. 1998 Apr 3;47(RR-3):1-29
pubmed: 9563847

Auteurs

Lucía Iglesias Vázquez (L)

Unit of Preventive Medicine and Public Health, Faculty of Medicine and Health Science, Universitat Rovira i Virgili, Reus, Spain.

Josefa Canals (J)

CRAMC (Centre de Recerca en Avaluació I Mesura de la Conducta), Unit of Psychology, Universitat Rovira i Virgili, Tarragona, Spain.

Núria Voltas (N)

CRAMC (Centre de Recerca en Avaluació I Mesura de la Conducta), Unit of Psychology, Universitat Rovira i Virgili, Tarragona, Spain.

Cristina Jardí (C)

Unit of Preventive Medicine and Public Health, Faculty of Medicine and Health Science, Universitat Rovira i Virgili, Reus, Spain.

Carmen Hernández (C)

CRAMC (Centre de Recerca en Avaluació I Mesura de la Conducta), Unit of Psychology, Universitat Rovira i Virgili, Tarragona, Spain.

Cristina Bedmar (C)

Unit of Preventive Medicine and Public Health, Faculty of Medicine and Health Science, Universitat Rovira i Virgili, Reus, Spain.

Joaquín Escribano (J)

Unit of Pediatrics, Faculty of Medicine and Health Science, Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili, Reus, Spain.
IISPV (Institut d'Investigació Sanitària Pere Virgili), Reus, Spain.

Núria Aranda (N)

Unit of Preventive Medicine and Public Health, Faculty of Medicine and Health Science, Universitat Rovira i Virgili, Reus, Spain.
IISPV (Institut d'Investigació Sanitària Pere Virgili), Reus, Spain.

Rosa Jiménez (R)

Unit of Pediatrics, Faculty of Medicine and Health Science, Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili, Reus, Spain.

Josep Maria Barroso (JM)

Unit of Pediatrics, Faculty of Medicine and Health Science, Hospital Universitari Sant Joan de Reus, Universitat Rovira i Virgili, Reus, Spain.

Blanca Ribot (B)

Unit of Preventive Medicine and Public Health, Faculty of Medicine and Health Science, Universitat Rovira i Virgili, Reus, Spain.

Victoria Arija (V)

Unit of Preventive Medicine and Public Health, Faculty of Medicine and Health Science, Universitat Rovira i Virgili, Reus, Spain. victoria.arija@urv.cat.
IISPV (Institut d'Investigació Sanitària Pere Virgili), Reus, Spain. victoria.arija@urv.cat.
IDIAP (Institut Universitari d'Investigació en Atenció Primària) Jordi Gol, Barcelona, Spain. victoria.arija@urv.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH